Cleo Diagnostics Ltd ACN 655 717 169 Notice of Annual General Meeting The Annual General Meeting of the Company will be held as follows: Time and date: 10.00am (AEDT) on Thursday, 26 November 2026 Location: Level 27, 120 Collins Street, Melbourne Victoria 3000 The Notice of Annual...
CLEO Diagnostics: Notice of Annual General Meeting/Proxy Form
Filed with ASX · · 29 pages · English
Release
Earlier from CLEO Diagnostics
- Notice Required Under ASX Listing Rule 3.13.1
- CLIA Certified Lab selected - Pivotal US Clinical Validation
- CLEO Receives First Batch of Commercial Test Kits
- Change of Director's Interest Notice x 4
- Cleansing Notice
Later from CLEO Diagnostics
- Letter to Shareholders
- CLEO Commences Ovarian Cancer Screening Test Development
- Cleo Files Patents for its Ovarian Cancer Screening Test
- CLEO Commences Analytical Validation Ahead of FDA Submission
- CLEO Screening Test Meets Rigorous Performance Targets
Follow CLEO Diagnostics into a list and get an email when it puts out news.
Follow CLEO Diagnostics